The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis

S Janz; M Krumbiegel; K Gawrisch

$The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis$

Journal article

Peer reviewed

The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis

S Janz, M Krumbiegel and K Gawrisch

Cancer biochemistry biophysics, Vol.13(2), pp.85-92

11/1992

PMID: 1343851

View Online

Abstract

The nature of the plasmacytomagenic activity of pristane (2,6,10,14-tetramethylpentadecane) is poorly defined. However, evidence for tumor promoting properties of pristane has recently come forward that includes direct cellular effects on B lymphocytes; i.e., the plasmacytoma precursor cell. Bly et al. (Cancer Biochem. Biophys. 11, 1990, 145-154) observed changed membrane fluidities in lymphocytes after administration of pristane in vivo. We measured steady-state fluorescence polarization using DPH (1,6-diphenyl-1,3,5-hexatriene) and APCL (1-acyl-2-[12-(9-anthryl)-11-trans-dodecenoyl]-sn-glycero-3- phosphocholine) as probes in DOPC (L-alpha-dioleoylphosphatidylcholin) model membranes and membrane fractions derived from plasmacytoma cells after incorporation of pristane in vitro. In a previous investigation, we verified the in vitro uptake of pristane into DOPC bilayers under the conditions employed here (Gawrisch and Janz, Biochim. Biophys. Acta 1070, 1991, 409-418). However, neither in DOPC bilayers nor in plasmacytoma membrane fractions could we detect changes in fluorescence polarization after in vitro incorporation of pristane within reasonable error limits. Therefore, we suggest that the observed alterations in membrane fluidity in lymphocytes from pristane-treated animals are the indirect result of the in vivo treatment but not a direct effect of pristane on membrane fluidity.

Plasmacytoma - chemically induced

Tumor Cells, Cultured - drug effects

Solubility

Terpenes - toxicity

Tumor Cells, Cultured - metabolism

Phosphatidylcholines - chemistry

Carcinogens - administration & dosage

Carcinogens - toxicity

Membrane Fluidity - drug effects

Plasmacytoma - metabolism

Animals

Terpenes - administration & dosage

Membrane Fluidity - physiology

Diphenylhexatriene

Cell Membrane - metabolism

Mice

Lipid Bilayers - chemistry

Fluorescence Polarization

Cell Membrane - drug effects

Details

Title: Subtitle: The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis
Creators: S Janz - Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Md 20892
M Krumbiegel
K Gawrisch
Resource Type: Journal article
Publication Details: Cancer biochemistry biophysics, Vol.13(2), pp.85-92
PMID: 1343851
ISSN: 0305-7232
Language: English
Date published: 11/1992
Academic Unit: Pathology
Record Identifier: 9984083838202771

Metrics

17 Record Views

6 Times Cited - Web of Science